• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    6 Ways ERP Systems Help Medical Device Manufacturers Manage Risk and Profitability

    Machining & Laser Processing Have Huge Parts to Play in Medtech Manufacturing

    Medtech R&D Teams Must Be Creative & Resilient to Survive

    Struggling Suppliers in Electronics Manufacturing Services (EMS)

    Deep (Brain) Thoughts with Medtronic's Neuromodulation President
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    Freudenberg Medical Adds Silicone Extrusion Capabilities in Massachusetts

    Positive Long-Term Prospects for Japanese Diabetes Care Market

    Digital X-Ray is as Effective as Lung Ventilation Perfusion in Detecting CTEPH

    CIBC Innovation Banking Provides $25M in Debt Financing to Podimetrics

    Invacare's Interim CEO Permanently Secures Job
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    6 Ways ERP Systems Help Medical Device Manufacturers Manage Risk and Profitability

    Machining & Laser Processing Have Huge Parts to Play in Medtech Manufacturing

    Medtech R&D Teams Must Be Creative & Resilient to Survive

    Struggling Suppliers in Electronics Manufacturing Services (EMS)

    Deep (Brain) Thoughts with Medtronic's Neuromodulation President
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Deducing the Dual Reality of Elizabeth Holmes

    The Return of the AdvaMed MedTech Conference…Live!

    Material Matters: New Materials Call for New Thinking

    5 Ways to Maintain a Talent-Centric Mindset, Even During Economic Uncertainty

    The Changing Face of UK Medical Device Regulations: Most Recent Update
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Arthur G. Russell Co. Inc., The

    Halkey-Roberts Corporation

    Paragon Medical

    LEMO USA Inc.

    Medbio LLC
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Onshoring Medical Device Manufacturing Can Strengthen Supply Chains

    How Artificial Intelligence Can Combat Key Issues Impacting Healthcare

    Why Advanced Sensors Are Crucial Within Medical Pumps

    How Artificial Intelligence Could Help Prevent 80% of Chronic Diseases

    4 Ways to Use Injection Molding in Medical Device Manufacturing
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Arthur G. Russell Co. Inc., The

    Halkey-Roberts Corporation

    Paragon Medical

    LEMO USA Inc.

    Medbio LLC
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Top30

    4. Royal Philips

    ...

    Related Content
    • Medical Devices Market to Top $671.49 Billion by 2027
    • HIMSS 2021: Philips Introduces Two New HealthSuite Solutions
    • Philips, Akumin Partner to Advance Radiology Performance and Quality
    • Promaxo Taps Srirama Venkataraman as VP of Clinical Research & Strategy
    • Substantial Growth Predicted for Global Ventilators Market
    07.26.18
    $16.3 Billion ($21.3B total)

    KEY EXECUTIVES:
    Frans van Houten, CEO and Chairman of the Board
    Egbert van Acht, Exec. VP, Personal Health Businesses
    Sophie Bechu, Exec. VP, Chief of Operations
    Abhijit Bhattacharya, Exec. VP and CFO
    Rob Cascella, Exec. VP, Diagnosis & Treatment Businesses
    Marnix van Ginneken, Exec. VP, Chief Legal Officer
    Andy Ho, Exec. VP, Greater China Market
    Henk de Jong, Exec. VP, Chief of International Markets (except Greater China & North America)
    Ronald de Jong, Exec. VP, Chief Human Resources Officer and Chairman of the Philips Foundation
    Carla Kriwet, Exec. VP, Connected Care & Health Informatics Businesses
    Vitor Rocha, Exec. VP, North American Market
    Jeroen Tas, Exec. VP, Chief Innovation and Strategy Officer

    NO. OF EMPLOYEES: 73,951

    GLOBAL HEADQUARTERS: Amsterdam, the Netherlands

    Without a doubt, there’s a major trend in the medical device space (and within its supply chain as well) that has companies buying other companies to grow their product portfolio, enter new markets, and expand capabilities. Alongside that, however, on a smaller scale (but no less significant) is another trend where a number of major firms are putting forth effort to target strategic industries and shed any businesses and units that don’t fit into that vision. In 2016, the industry saw Danaher absolve itself of Fortive, which represented the firm’s professional instrumentation and industrial technologies businesses. A year earlier, Baxter was split to see Baxalta, a pharmaceutical-focused entity, emerge as an independent company. In more recent news, GE has announced it will spin out its Healthcare business to become a standalone firm. Philips decided it would venture down a similar path.

    Philips has been transitioning to be more focused exclusively as a global provider of medical technology since it made the announcement in 2014. It’s since spun out the lighting unit and by the end of 2017, was almost entirely focused on healthcare devices. The remaining exceptions live within the Personal Health segment. The non-health tech segments include its Personal Care unit, which offers male grooming and beauty products, and Domestic Appliances, which consists of kitchen appliances, coffee, air, garment care, and floor care. The remainder of Philips is dedicated to the medical device industry. Whether the company will move the two remaining non-medical units (which still account for a fair share of the firm’s net sales) in the coming years remains to be seen.

    As a result of the company’s strategic efforts, Philips announced in March 2017 that the firm’s sector classification had been changed within the STOXX Europe 600 Index from Industrial Goods & Services to Health Care. “The STOXX sector reclassification to Health Care underlines the significant steps that we have taken to transform Philips into a focused leader in health technology,” said Frans van Houten, CEO of Royal Philips. “2016 was a defining year in our transformation, and we have seen the results of our strategic focus reflected in our performance and the positive response from our stakeholders, including our employees, customers, and shareholders. This reclassification will further facilitate the comparison with sector peers and support the investment community to value Philips going forward.”

    As mentioned previously, the major move to refocus its attention on healthcare required Philips to cut ties with the lighting segment, which was almost completed by the end of the 2017 fiscal year. In fact, the company’s shareholding in Philips Lighting was decreased to 29.01 percent (compared to its 71.23 percent stake following the listing of Philips Lighting on Euronext in Amsterdam in May 2016). In addition, in June 2017, Philips further separated itself from the lighting industry as it completed the sale of an 80.1 percent interest in Lumileds, a supplier of LED components and automotive lighting, to Apollo Global Management LLC. The sale, coupled with the split from Philips Lighting (now renamed Signify), empowered the company to truly focus its attention on the medtech space. A review of the firm’s acquisitions in 2017 to expand its healthcare technology-related capabilities reveals that the company didn’t take long to get started on that focus.


    ANALYST INSIGHTS: For the most part, Philips has now made the transition from a multi-industry conglomerate to a focused healthcare company. To emphasize its focus on medical and life sciences, Philips has announced it’s moving its North American HQ to Cambridge. It’s an expensive investment that is also a statement that Philips is “here to stay” across the healthcare spectrum. Watch for Philips to continue to seek to deliver across the boundaries of both consumer and acute healthcare in a meaningful way.

    —Dave Sheppard, Co-Founder and Principal, MedWorld Advisors



    Most notable during the 2017 fiscal year was the purchase of The Spectranetics Corporation. Announced at the end of June and completed by the second week of August, the $2.16 billion (1.9 billion euro) price tag reflected the 27 percent premium Philips offered to shareholders for the vascular intervention and lead management business. Spectranetics was positioned within Philips’ Image-Guided Therapy Business Group, which serves a market valued at over 6 billion euro.

    “The completion of this acquisition will accelerate the realization of our strategic expansion into therapy devices. The combination of Spectranetics’ highly competitive product range and our portfolio of interventional imaging systems, devices, software, and services will deliver enhanced care for patients by enabling clinicians to decide, guide, treat, and confirm the appropriate cardiac and peripheral vascular treatment,” van Houten said in a company statement.

    That “highly competitive product range” includes catheters to treat coronary and peripheral artery disease, and remove implanted pacemaker and implantable cardioverter defibrillator leads. One of the portfolio’s leading products was the Stellarex drug-coated balloon, which provides peripheral artery disease treatment and is backed by robust clinical evidence. At the time the acquisition closed, Stellarex had a CE mark and had also gained PMA approval from the U.S. Food and Drug Administration (FDA).

    While representing a substantial price tag, the Spectranetics acquisition was just one of several transactions Philips conducted in 2017 in its quest to reshape the company into a focused healthcare technology giant. In March, the organization bought Australian Pharmacy Sleep Services (APSS), a provider of pharmacy sleep testing. The buy was a complementary piece to Philips’ sleep and respiratory care offering. It was also an attractive target as it was believed the company would help accelerate Philips’ home sleep testing offering through the pharmacy channel in Australia. The primary offering of APSS was a sleep apnea program for pharmacies that included screening, home-based sleep studies based on continuous positive airway pressure therapy, training, and services.

    The summer of 2017 heated up for Philips as a result of its strong M&A activity from June through August. The company made an additional three purchases beyond the aforementioned Spectranetics deal and closed the sale of one of its businesses for a stake in the acquiring company. The first buy, announced in June, was Electrical Geodesics Inc. (EGI)—a U.S.-based company that designed, developed, and commercialized a range of non-invasive technologies used to monitor and interpret brain activity—for 32.9 million euro. EGI’s technologies were viewed as logical expansion of Philips’ own similar product portfolio. Combined, the company could use the innovations to address neurological disorders such as stroke, epilepsy, traumatic brain injury, and Parkinson’s disease.

    “In order to improve the treatment for some of the most complicated, life-altering neurological disorders, we need more personalized and adaptive guidance tools to plan each individual patient’s therapeutic options,” said Joe Burnett, business leader, Neuro Diagnostics at Philips. “This acquisition will enable Philips to provide an integrated neurology solution comprising diagnostic imaging and clinical informatics to assess brain anatomy and physiological processes, and EEG mapping tools from EGI to measure electrical brain activity. By fusing these different tools together, we will create a more comprehensive map of the brain, and unlock new computational algorithms which will help to shorten the path to a definitive diagnosis and guide some of the most complex therapeutic strategies.”

    Setting off some fireworks of its own, Philips announced on July 4 that it was acquiring Health & Parenting Ltd., a London-based developer of healthcare and family-related mobile applications for expectant and new parents. The firm’s top app, Pregnancy+, had been downloaded more than 12 million times. Health & Parenting’s apps would join the Philips uGrow digital parenting platform.

    Seeking to enhance its ultrasound business, it was announced in mid-July that TomTec Imaging Systems GmbH would become a part of Philips. TomTec was a provider of intelligent image analysis software, especially for diagnostic ultrasound. The buy would positively impact Philips’ cardiac ultrasound, obstetrics, and gynecology offerings. The TomTec software was being used by more than 20,000 physicians and 600 healthcare facilities around the world.

    At the start of August, Philips announced another transaction that, while technically saw it selling a business, ultimately resulted in the acquisition of a stake in the purchasing company. The Canadian-based Profound Medical Corp. bought Philips’ Magnetic Resonance-Guided High Intensity Focused Ultrasound business in exchange for 7.4  million Profound common shares, approximately 13 percent of the firm’s issued and outstanding common shares. The company’s primary product, TULSA-PRO, combines real-time magnetic resonance imaging with transurethral, robotically-driven therapeutic ultrasound and closed-loop thermal feedback control designed to provide precise ablation of the prostate while simultaneously protecting critical surrounding anatomy from potential side effects.

    Right about the time the United States was feeling the effects of its annual turkey dinner celebration, Philips announced it was a buying a U.S.-based startup. Founded in 2011 with technology licensed from the University of Maryland School of Medicine, Analytical Informatics brought a suite of workflow improvement applications to Philips to enhance the company’s PerformanceBridge portfolio of operational performance improvement tools and services, which addresses the needs of radiology departments.

    “Integrating Analytical Informatics’ software tools and applications into our current offerings will enable us to accelerate the delivery of next-generation technology, software, and services, to bring the power of operational intelligence and decision support to radiology,” said Sham Sokka, general manager of Radiology Solutions at Philips.

    Finally, rounding out the 2017 fiscal, the company brought aboard Forcare, an innovator in open-standards-based interoperability software solutions for fast and flawless data flows between medical systems and information sources at the departmental and enterprise levels, as well as health information exchanges across health systems. The technology addresses the needs of healthcare systems that are being consolidated to enable seamless enterprise integration.

    “We have a leading position in building bridges between information systems, so that care providers can instantly share clinical results, images, and letters,” said Harm-Jan Wessels, CEO of Forcare.

    Bringing these new capabilities into Philips will only help the firm better serve the strategic markets it has selected to focus on. All of the acquired firms join a company that is well established with a solid financial record. In 2017, Philips boasted total company sales of 17.8 billion euros, which represented a 4 percent increase over 2016 in comparable sales growth. Pulling out the two non-medical device segments results in 2017 sales of 13.6 billion euros.

    Personal Health is Philips’ largest segment in terms of sales (among the three primary businesses) and home to two medical device units—Health & Wellness and Sleep & Respiratory Care—alongside the two “other” aforementioned units—Personal Care and Domestic Appliances. The segment enjoyed a 3 percent increase in nominal sales growth over 2016, reaching 7.3 billion euros. The successes were primarily driven by an increase in sales in growth geographies (7 percent), but the business saw successes in its digital health and dental products.

    Comprising the Diagnosis & Treatment segment are Diagnostic Imaging, Image-Guided Therapy, and Ultrasound. The unit’s performance was bolstered by the global launch of Azurion, an image-guided therapy platform that enables clinicians to perform a wide range of routine and complex procedures. Further, a strategic alliance with B. Braun to innovate and accelerate growth in ultrasound-guided regional anesthesia and vascular access resulted in the launch of Xperius. The co-branded mobile ultrasound system was developed specifically to support current and future solutions in the market. As a result, the business saw a 3 percent growth in nominal sales over 2016 to achieve 6.9 billion euros.

    The Connected Care & Health Informatics business houses the Patient Care & Monitoring Solutions, Healthcare Informatics, and Population Health Management units. New hospital agreements for data analytics solutions, clinical informatics and services, clinical IT, and patient monitoring capabilities highlighted the sales in this business, but ultimately, the division experienced no sales growth over the prior year, finishing 2017 with 3.2 billion euros in sales.

    Not satisfied with the status quo (as witnessed from the aggressive M&A activity), the company also announced a host of products that will likely be instrumental in its growth going forward.
    Following are several highlighted technologies that could make a splash in the coming years for Philips’ sales figures.

    IntelliSpace Enterprise Edition for Radiology—A comprehensive managed solution for enterprise imaging.

    Technology Maximizer—A cross-modality program designed to boost the clinical capabilities and performance of imaging equipment through proactive upgrades.

    IntelliSpace Portal 10—The latest edition of Philips’ comprehensive, advanced visualization and quantification platform.

    IQon Elite Spectral CT—Provides clinicians with increased diagnostic certainty in every scan.

    eL18-4 transducer—A full solution for small parts imaging, which is used to assess diseases and disorders of small organs, such as breasts, testicles, and thyroid, as well as musculoskeletal injuries like sprains and tears.

    Philips BlueControl wearable light therapy device—Treats mild psoriasis.

    IntelliVue X3—Provides an intuitive smartphone-style operation that quickly and easily enables continuous monitoring during transport for the most critical patients.

    IntelliSite Pathology Solution—A comprehensive digital pathology system designed to meet the challenges of today’s pathology lab.

    ElastQ Imaging—Enables simultaneous imaging of tissue and assessment of its stiffness, which is essential for the diagnosis of various liver conditions.

    IntelliVue Guardian Solution—Designed to aid clinicians in the early detection of subtle signs of patient deterioration in the general care ward.
    Related Searches
    • ge
    • company
    • technologies
    • health
    Suggested For You
    Medical Devices Market to Top $671.49 Billion by 2027 Medical Devices Market to Top $671.49 Billion by 2027
    HIMSS 2021: Philips Introduces Two New HealthSuite Solutions HIMSS 2021: Philips Introduces Two New HealthSuite Solutions
    Philips, Akumin Partner to Advance Radiology Performance and Quality Philips, Akumin Partner to Advance Radiology Performance and Quality
    Promaxo Taps Srirama Venkataraman as VP of Clinical Research & Strategy Promaxo Taps Srirama Venkataraman as VP of Clinical Research & Strategy
    Substantial Growth Predicted for Global Ventilators Market Substantial Growth Predicted for Global Ventilators Market
    Royal Philips Enters Strategic Partnership with NICO.LAB Royal Philips Enters Strategic Partnership with NICO.LAB
    Enrollment Underway in Philips Enrollment Underway in Philips' WE-TRUST Stroke Study
    Philips Recalls Certain Sleep and Respiratory Care Devices Philips Recalls Certain Sleep and Respiratory Care Devices
    Philips, Ibex Medical Analytics Partner to Accelerate Adoption of AI-Powered Digital Pathology Philips, Ibex Medical Analytics Partner to Accelerate Adoption of AI-Powered Digital Pathology
    Philips, UCSF Team Up to Enhance Digital Patient Experience Philips, UCSF Team Up to Enhance Digital Patient Experience
    Neuronetics Appoints Robert Cascella to its Board of Directors Neuronetics Appoints Robert Cascella to its Board of Directors
    Paige Appoints Chief Commercial Officer and Medical Director Paige Appoints Chief Commercial Officer and Medical Director
    Connect America to Buy Philips Connect America to Buy Philips' Aging and Caregiving Biz
    PENTAX Appoints Former Philips VP Ojas A. Buch as President, Americas PENTAX Appoints Former Philips VP Ojas A. Buch as President, Americas
    Device Companies to Help AI Market Reach $52 Billion in 2024 Device Companies to Help AI Market Reach $52 Billion in 2024

    Related Breaking News

    • Medical Devices Market to Top $671.49 Billion by 2027

      Medical Devices Market to Top $671.49 Billion by 2027

      Wearables and rising cases of chronic diseases will help fuel growth, industry data predicts.
      Precedence Research 09.16.21

    • Digital Health | Software & IT
      HIMSS 2021: Philips Introduces Two New HealthSuite Solutions

      HIMSS 2021: Philips Introduces Two New HealthSuite Solutions

      Cloud-based solutions for orchestrated patient logistics and enterprise telehealth for acute care.
      GlobeNewswire 08.09.21

    • Philips, Akumin Partner to Advance Radiology Performance and Quality

      Philips, Akumin Partner to Advance Radiology Performance and Quality

      Partnership leverages Philips’ Radiology Operations Command Center to improve the access, quality, productivity of Akumin’s outpatient imaging center network.
      Royal Philips 08.05.21


    • Promaxo Taps Srirama Venkataraman as VP of Clinical Research & Strategy

      Promaxo Taps Srirama Venkataraman as VP of Clinical Research & Strategy

      With previous roles at Philips and Stryker, Dr. Venkataraman will bring his expertise to Promaxo’s MRI and robotic platform.
      Business Wire 07.30.21

    • Substantial Growth Predicted for Global Ventilators Market

      Substantial Growth Predicted for Global Ventilators Market

      Aging population, increasing infectious disease rates to drive growth through 2026.
      Market Study Report 07.13.21

    Loading, Please Wait..

    Trending
    • CGM Devices Could Become Main Glucose Monitoring Solution In U.S.
    • Study: Smartphone Therapeutic Helps Improve Fibromyalgia In Patients
    • MO SCI Acquires Assets Of 3M’s Advanced Materials Business
    • Positive Long-Term Prospects For Japanese Diabetes Care Market
    • The Future Of Biomedical Engineering Advancements
    Breaking News
    • Freudenberg Medical Adds Silicone Extrusion Capabilities in Massachusetts
    • Positive Long-Term Prospects for Japanese Diabetes Care Market
    • Digital X-Ray is as Effective as Lung Ventilation Perfusion in Detecting CTEPH
    • CIBC Innovation Banking Provides $25M in Debt Financing to Podimetrics
    • Invacare's Interim CEO Permanently Secures Job
    View Breaking News >
    CURRENT ISSUE

    January/February 2023

    • Struggling Suppliers in Electronics Manufacturing Services (EMS)
    • Machining & Laser Processing Have Huge Parts to Play
    • Medtech R&D Teams Must Be Creative & Resilient to Survive
    • Medtronic Neuromodulation President, Nnamdi Njoku, Interview
    • 6 Ways ERP Systems Help Medical Device Manufacturers Manage Risk and Profitability
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    NPA Announces Annual Capitol Hill Advocacy ‘Fly-In’ Day
    GOED Elects New Board Officers for 2023
    Aspire Hires Darrec Jones as VP of Business Development
    Coatings World

    Latest Breaking News From Coatings World

    Caren Hoffmann Appointed Vice President for BASF Mining Solutions
    Microban International Announces Four Senior Hires
    PPG Completes COLORFUL COMMUNITIES Project in Denmark
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Freudenberg Medical Adds Silicone Extrusion Capabilities in Massachusetts
    Positive Long-Term Prospects for Japanese Diabetes Care Market
    Digital X-Ray is as Effective as Lung Ventilation Perfusion in Detecting CTEPH
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Bristol Myers Squibb 4Q Results
    Actinium, NCI Partner to Develop Actimab-A in AML
    Astellas Announces New President and CEO and Management Structure
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Old Spice Introduces New Mascot and Launches ‘Smelf-Confidence’ Campaign
    KVD Beauty Launches Good Apple Serum Foundation
    Interpack 2023 to Focus on Sustainability
    Happi

    Latest Breaking News From Happi

    EvaClean Promotes Nicole Slacik to Executive Vice President, Healthcare
    Personal Care Brand Odele Expands into Ulta Beauty
    Clorox’s Eric Reynolds Elected Chair of American Cleaning Institute’s Board of Directors
    Ink World

    Latest Breaking News From Ink World

    Mexar Limited Awarded OEKO-TEX ECO PASSPORT Certification
    Graphic Packaging Named to Fortune's List of World's Most Admired Companies
    CDP Awards Amcor an A- for Ongoing Work on Climate Change Disclosure
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Fujifilm expands RxD inkjet pigment dispersions color range
    Anderson & Vreeland acquires flexo consumable assets from Grimco
    Hamillroad Software's Bellissima DMS honored in Brazil
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Avgol to Showcase Algaeing Colorants and Fibers at Filtech
    Uster to Host Webinar on Zero-Level Contamination Control
    Typar Expands Drainable Wrap Line
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Steady Growth Forecast for Global Orthobiologics Market
    ODT's Most-Read Stories This Week—Feb. 4
    Toetal Solutions Secures $1.8 Million in New Financing
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    onsemi Exceeds 4Q 2022 Expectations
    Emerson Launches Ovation Green Software Portfolio
    Graphene Flagship Researchers Examine Applications for Space

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login